{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:28:27Z","timestamp":1791829707515,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejca.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T01:48:20Z","timestamp":1433555300000},"page":"1742-1750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":407,"title":["Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer \u2013 A pooled analysis of PORTEC 1 and 2 trials"],"prefix":"10.1016","volume":"51","author":[{"given":"Tjalling","family":"Bosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke E.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina M.","family":"J\u00fcrgenliemk-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Jobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem M.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludy C.H.W.","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta M.","family":"van der Steen-Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.H.B.M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejca.2015.05.015_b0005","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2015.05.015_b0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology","volume":"18","author":"Chi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"8 Suppl.","key":"10.1016\/j.ejca.2015.05.015_b0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2015.05.015_b0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/gyno.2002.6825","article-title":"Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?","volume":"87","author":"Cohn","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2015.05.015_b0025","first-page":"1715","article-title":"Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I\u2013II endometrioid-type endometrial cancer","volume":"29","author":"Gadducci","year":"2009","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.ejca.2015.05.015_b0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejso.2007.01.009","article-title":"Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study","volume":"33","author":"Gemer","year":"2007","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.05.015_b0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.05.015_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajo.12089","article-title":"Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer","volume":"53","author":"Hahn","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.ejca.2015.05.015_b0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1471-0528.2009.02162.x","article-title":"Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality","volume":"116","author":"O\u2019Brien","year":"2009","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.ejca.2015.05.015_b0050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00404-013-2913-x","article-title":"Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer","volume":"288","author":"Vaizoglu","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ejca.2015.05.015_b0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphvascular space involvement: an independent prognostic factor in endometrial cancer","volume":"96","author":"Briet","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.05.015_b0060","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9213","key":"10.1016\/j.ejca.2015.05.015_b0065","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"9658","key":"10.1016\/j.ejca.2015.05.015_b0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC Group","year":"2009","journal-title":"Lancet"},{"issue":"9717","key":"10.1016\/j.ejca.2015.05.015_b0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejca.2015.05.015_b0080","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejca.2015.05.015_b0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance","volume":"22","author":"Murray","year":"2003","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ejca.2015.05.015_b0090","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ygyno.2008.10.019","article-title":"Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence","volume":"112","author":"Fujimoto","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2015.05.015_b0095","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7","article-title":"The grading of lymphovascular space invasion in endometrial carcinoma","volume":"86","author":"Hachisuga","year":"1999","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.05.015_b0100","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/1097-0142(19920315)69:6<1424::AID-CNCR2820690620>3.0.CO;2-5","article-title":"Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus","volume":"69","author":"Ambros","year":"1992","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.ejca.2015.05.015_b0105","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.05.015_b0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2006.10.013","article-title":"Endometrial cancer\u2013revisiting the importance of pelvic and para aortic lymph nodes","volume":"104","author":"Aalders","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.05.015_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2015.05.015_b0120","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.ejca.2015.05.015_b0125","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.05.015_b0130","doi-asserted-by":"crossref","unstructured":"McMeekin DS, Filiaci VL, Aghajanian C. A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy (VCB\/C) in patients with high risk (HR), early stage endometrial cancer (EC): a Gynecologic Oncology Group trial. Late-breaking Abstract 1, Society of Gynecological Oncology Meeting 2014 2014.","DOI":"10.1016\/j.ygyno.2014.07.078"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915004463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915004463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:36:14Z","timestamp":1566794174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915004463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0959804915004463"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.05.015","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer \u2013 A pooled analysis of PORTEC 1 and 2 trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}